DK1608982T3 - Diagnose af autisme - Google Patents

Diagnose af autisme

Info

Publication number
DK1608982T3
DK1608982T3 DK04716392T DK04716392T DK1608982T3 DK 1608982 T3 DK1608982 T3 DK 1608982T3 DK 04716392 T DK04716392 T DK 04716392T DK 04716392 T DK04716392 T DK 04716392T DK 1608982 T3 DK1608982 T3 DK 1608982T3
Authority
DK
Denmark
Prior art keywords
seq
autism
diagnosis
peptides
skithrihwesasll
Prior art date
Application number
DK04716392T
Other languages
Danish (da)
English (en)
Inventor
Anders Grubb
Original Assignee
Momeni Naghi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momeni Naghi filed Critical Momeni Naghi
Application granted granted Critical
Publication of DK1608982T3 publication Critical patent/DK1608982T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK04716392T 2003-03-04 2004-03-02 Diagnose af autisme DK1608982T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0300586A SE0300586L (sv) 2003-03-04 2003-03-04 Diagnos av autism
PCT/SE2004/000193 WO2004079371A1 (fr) 2003-03-04 2004-03-02 Diagnostic de l'autisme

Publications (1)

Publication Number Publication Date
DK1608982T3 true DK1608982T3 (da) 2007-11-26

Family

ID=20290572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04716392T DK1608982T3 (da) 2003-03-04 2004-03-02 Diagnose af autisme

Country Status (19)

Country Link
US (1) US8268576B2 (fr)
EP (1) EP1608982B9 (fr)
JP (1) JP4452715B2 (fr)
KR (1) KR101096487B1 (fr)
CN (1) CN1795386B (fr)
AT (1) ATE371192T1 (fr)
AU (1) AU2004217571B2 (fr)
BR (1) BRPI0408067A (fr)
CA (1) CA2518066C (fr)
DE (1) DE602004008439T2 (fr)
DK (1) DK1608982T3 (fr)
ES (1) ES2293234T3 (fr)
NZ (1) NZ542149A (fr)
PL (1) PL1608982T3 (fr)
PT (1) PT1608982E (fr)
RU (1) RU2340900C2 (fr)
SE (1) SE0300586L (fr)
WO (1) WO2004079371A1 (fr)
ZA (1) ZA200507082B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4677556B2 (ja) * 2005-04-22 2011-04-27 国立大学法人 千葉大学 自閉症の診断薬
WO2009012595A1 (fr) * 2007-07-26 2009-01-29 Phenomenome Discoveries Inc. Procédés pour le diagnostic, l'évaluation de risque et la surveillance de troubles du spectre autistique
EP2651972B1 (fr) * 2010-12-16 2016-04-06 Autism Biotech Limited Nouveau biomarqueur et ses utilisations dans le diagnostic, le traitement de l'autisme
AU2013293167B2 (en) 2012-07-22 2019-04-18 Indiana University Research And Technology Corporation Modulation sAPP, sAPP alpha and BDNF levels in individuals diagnosed with FXS and ASD
DK3058371T3 (da) 2013-10-14 2021-08-02 Univ Indiana Res & Tech Corp Anvendelse af acamprosat til at modulere erk-1-2-aktivering i dyremodeller til fxs og asd og individer diagnosticeret med fxs og asd
CN105652016A (zh) * 2016-01-28 2016-06-08 深圳大学 一种孤独症检测标志物及其检测方法
KR102083245B1 (ko) 2017-03-10 2020-03-02 스핑고브레인 주식회사 정신장애의 진단 방법
US11131681B2 (en) * 2017-03-10 2021-09-28 Dr. Raymond Laboratories, Inc. Method for diagnosing psychiatric disorders
RU2643760C1 (ru) * 2017-08-07 2018-02-05 Федеральное государственное бюджетное научное учреждение "Научный центр психического здоровья" Способ определения необходимости использования психофармакотерапии у пациентов с расстройствами аутистического спектра на момент их обследования
KR20190106442A (ko) 2018-03-09 2019-09-18 스핑고브레인 주식회사 태지, 양수 또는 제대혈을 이용한 정신장애의 진단 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273683A1 (fr) * 1998-06-15 1999-12-15 Ortho-Clinical Diagnostics, Inc. Marqueurs pour le diagnostic de troubles chez l'etre humain
IT1303675B1 (it) * 1998-08-04 2001-02-23 Radim S P A Metodo di determinazione di peptidi utilizzati come marker per ladiagnosi dell'autismo
AU1582401A (en) * 1999-11-04 2001-05-14 Human Genome Sciences, Inc. Uteroglobin-like polynucleotides, polypeptides, and antibodies
US6998243B2 (en) 2001-04-30 2006-02-14 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons

Also Published As

Publication number Publication date
WO2004079371A1 (fr) 2004-09-16
EP1608982A1 (fr) 2005-12-28
ES2293234T3 (es) 2008-03-16
ATE371192T1 (de) 2007-09-15
CA2518066A1 (fr) 2004-09-16
AU2004217571B2 (en) 2009-03-12
SE0300586L (sv) 2004-09-05
DE602004008439T2 (de) 2008-05-21
DE602004008439D1 (de) 2007-10-04
CN1795386A (zh) 2006-06-28
SE0300586D0 (sv) 2003-03-04
RU2340900C2 (ru) 2008-12-10
CA2518066C (fr) 2011-05-10
EP1608982B9 (fr) 2008-07-23
KR101096487B1 (ko) 2011-12-20
ZA200507082B (en) 2007-02-28
JP4452715B2 (ja) 2010-04-21
NZ542149A (en) 2008-03-28
US8268576B2 (en) 2012-09-18
PL1608982T3 (pl) 2008-01-31
PT1608982E (pt) 2007-11-09
EP1608982B1 (fr) 2007-08-22
KR20060006774A (ko) 2006-01-19
AU2004217571A1 (en) 2004-09-16
BRPI0408067A (pt) 2006-02-14
US20120149038A1 (en) 2012-06-14
CN1795386B (zh) 2010-08-25
JP2006519391A (ja) 2006-08-24
RU2005130641A (ru) 2006-02-10

Similar Documents

Publication Publication Date Title
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
HK1089232A1 (en) Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
MA29282B1 (fr) Procede de diagnostic d'une steatose hepatique au moyen de marqueurs biochimiques
DK1608982T3 (da) Diagnose af autisme
DE69922261D1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE602004011105D1 (de) Verfahren, peptide und biosensoren mit eignung zum nachweis eines breiten spektrums von bakterien
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
DE602005012530D1 (de) Immunogene glykopeptide zur diagnose von infektionen pathogener mikroorganismen
DE60326153D1 (de) Verfahren zur diagnose von morbus alzheimer
ATE360034T1 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
CA2366523A1 (fr) Procede d'analyse de la quantite de tissu adipeux intra-abdominal
BR0317404A (pt) Variantes do fator xiia
ATE511646T1 (de) Diagnose mykobakterieller infektionen mittels bestimmung von ifn-gamma
DE60334408D1 (de) Nsäuren
EP2290093A3 (fr) Procédé de détection de la PRP utilisant une molécule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
GB0223655D0 (en) Method of diagnosis
DE602004022995D1 (de) Verfahren zur diagnose der immunität wiederkehrendren zur behandlung und überwachung
ATE390435T1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie
ATE369426T1 (de) Nukleinsäure- und aminosäuresequenzen von durch hämoglobin induzierbaren genen aus candida albicans und die verwendung dieser sequenzen in reagenzien zur diagnose von disseminierten candida albicans infektionen
ATE478147T1 (de) Aus einem neuroblastom isolierte nukleinsäuren
PT1527197E (pt) Associação do polimorfismo v286a da edg5 com diabetes mellitus do tipo ii e trombose venosa/embolismo pulmonar e a sua utilização
CA2588614A1 (fr) Procede d'analyse de la quantite de tissu adipeux intra-abdominal
WO2002065129A3 (fr) Procedes